WA

Waqas Abdul Azeez

Active Director Designated Partner DIN 11009232
DIN 11009232 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Waqas Abdul Azeez

Data last updated:

Waqas Abdul Azeez is a Designated Partner at Harrow Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11009232
Primary Designation Designated Partner
Industry Pharma
First Appointment 20 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Mar 20252025Active

Board colleagues of Waqas Abdul Azeez

NameDINCompanyDesignation
Abdulazeez Kolukki Puthanpurayil07134402Harrow Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Harrow Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Waqas Abdul Azeez

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Waqas Abdul Azeez

Waqas Abdul Azeez currently holds 1 directorship: Harrow Pharmaceuticals Llp (Designated Partner, since 20 Mar 2025).

Waqas Abdul Azeez was first appointed on 20 Mar 2025 as Designated Partner at Harrow Pharmaceuticals Llp.

The current boards of Waqas Abdul Azeez's companies include Abdulazeez Kolukki Puthanpurayil (Harrow Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available